Company’s 36-month beta value is 1.96.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for ZIMV is 26.38M, and currently, short sellers hold a 3.36% ratio of that floaft. The average trading volume of ZIMV on June 25, 2024 was 268.70K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ZIMV) stock’s latest price update
ZimVie Inc (NASDAQ: ZIMV) has seen a rise in its stock price by 5.57 in relation to its previous close of 14.79. However, the company has experienced a 0.61% gain in its stock price over the last five trading sessions. globenewswire.com reported 2024-05-16 that PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) — ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.
ZIMV’s Market Performance
ZIMV’s stock has risen by 0.61% in the past week, with a monthly drop of -6.61% and a quarterly drop of -2.47%. The volatility ratio for the week is 2.86% while the volatility levels for the last 30 days are 3.43% for ZimVie Inc The simple moving average for the last 20 days is -2.81% for ZIMV stock, with a simple moving average of 9.39% for the last 200 days.
Analysts’ Opinion of ZIMV
Many brokerage firms have already submitted their reports for ZIMV stocks, with Needham repeating the rating for ZIMV by listing it as a “Buy.” The predicted price for ZIMV in the upcoming period, according to Needham is $20 based on the research report published on May 16, 2024 of the current year 2024.
Barclays gave a rating of “Underweight” to ZIMV, setting the target price at $9 in the report published on December 21st of the previous year.
ZIMV Trading at -3.05% from the 50-Day Moving Average
After a stumble in the market that brought ZIMV to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.33% of loss for the given period.
Volatility was left at 3.43%, however, over the last 30 days, the volatility rate increased by 2.86%, as shares sank -10.48% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -5.47% lower at present.
During the last 5 trading sessions, ZIMV fell by -3.16%, which changed the moving average for the period of 200-days by +37.39% in comparison to the 20-day moving average, which settled at $15.98. In addition, ZimVie Inc saw -12.03% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for ZIMV
Current profitability levels for the company are sitting at:
- 0.05 for the present operating margin
- 0.71 for the gross margin
The net margin for ZimVie Inc stands at -0.56. The total capital return value is set at 0.03. Equity return is now at value -10.97, with -4.50 for asset returns.
Based on ZimVie Inc (ZIMV), the company’s capital structure generated 0.57 points at debt to capital in total, while cash flow to debt ratio is standing at 0.06. The debt to equity ratio resting at 1.32. The interest coverage ratio of the stock is 3.45.
Currently, EBITDA for the company is 110.43 million with net debt to EBITDA at 4.4. When we switch over and look at the enterprise to sales, we see a ratio of 1.45. The receivables turnover for the company is 9.56for trailing twelve months and the total asset turnover is 0.56. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.68.
Conclusion
In a nutshell, ZimVie Inc (ZIMV) has experienced a mixed performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
